Kidney tumours: Difference between revisions
Jump to navigation
Jump to search
→Wilms tumour: +syndromes |
No edit summary |
||
| (340 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Kidney tumours''' - includes '''malignant kidney tumours''' and '''benign kidney tumours'''. Medical renal diseases are dealt with in the [[medical renal diseases]] article. | [[Image:Renal oncocytoma.jpg|thumb|250px|A kidney tumour ([[renal oncocytoma]]). (WC/Emmanuelm)]] | ||
'''[[Kidney]] tumours''' - includes '''malignant kidney tumours''' ('''kidney cancer''') and '''benign kidney tumours'''. Medical renal diseases are dealt with in the [[medical renal diseases]] article. | |||
Pediatric kidney tumours are dealt with in the ''[[pediatric kidney tumours]]'' article. | |||
=Renal specimens= | =Renal specimens= | ||
*Renal biopsy - usually for renal | *[[Renal biopsy]] - usually for [[renal oncocytoma]] vs. renal cell carcinoma (RCC) ''or'' medical diseases - see ''[[medical kidney]]''. | ||
*Partial nephrectomy. | *[[Partial nephrectomy]]. | ||
*Nephrectomy. | *[[Nephrectomy]]. | ||
*Nephroureterectomy (includes ureter) - done for [[urothelial cell carcinoma]] (UCC) of the renal pelvis and ureteric UCC. | *[[Nephroureterectomy]] (includes [[ureter]]) - done for [[urothelial cell carcinoma]] (UCC) of the renal pelvis and ureteric UCC. | ||
*Radical nephrectomy | *[[Radical nephrectomy]] - includes Gerota's fascia. | ||
**May include the [[adrenal gland]].<ref name=Ref_WMSP|288>{{Ref WMSP|288}}</ref> | |||
In excisions done for tumours, a comment should be made about kidney distant from the tumour. People with less renal mass, i.e. less kidney, are predisposed to focal segmental glomerulosclerosis (FSGS). | |||
==Anatomy== | |||
Layers (superficial to deep): | |||
#Renal fascia (Gerota's fascia). | |||
#Perinephric fat. | |||
#Renal capsule. | |||
#Renal parenchyma (cortex). | |||
===Sign out=== | |||
====Missed renal biopsy==== | |||
{{Main|Missed renal biopsy}} | |||
=Tabular comparison (selected tumours)= | =Tabular comparison (selected tumours)= | ||
Selected common tumours of the kidney:<ref>{{Ref GUP|281-304}}</ref><ref name=pmid19494850>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue = | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}</ref> | Selected common tumours of the kidney:<ref name=Ref_GUP281>{{Ref GUP|281-304}}</ref><ref name=pmid19494850>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue = | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
| | | | ||
| Line 63: | Line 78: | ||
|- | |- | ||
|IHC | |IHC | ||
| CK7-, EMA+ | | [[CK7]]-, EMA+ | ||
| AMACR+, EMA+, CK7+ | | AMACR+, EMA+, CK7+ | ||
| AMACR+, E-cadherin+, CK7- | | AMACR+, E-cadherin+, CK7- | ||
| Line 87: | Line 102: | ||
|- | |- | ||
|Image(s) | |Image(s) | ||
| [ | | [[Image:Renal_clear_cell_ca_%281%29_Nephrectomy.jpg|thumb|150px| CCRCC (WC)]] | ||
| [ | | [[Image:Papillary_renal_cell_carcinoma_intermed_mag.jpg|thumb|150px| PaRCC - intermed. (WC)]], [[Image:Papillary_renal_cell_carcinoma_very_high_mag.jpg | thumb|150px| PaRCC - high (WC)]] | ||
| | | | ||
| | | | ||
| [ | | [[Image:Oncocytic_chromophobe_rcc_high_mag.jpg|thumb|150px| ChRCC (WC)]] | ||
| [ | | [[Image:Renal_oncocytoma2.jpg|thumb|150px| Oncocytoma (WC)]] | ||
|} | |} | ||
Notes: | Notes: | ||
| Line 98: | Line 113: | ||
===Tabular comparison of oncocytoma and chromophobe RCC=== | ===Tabular comparison of oncocytoma and chromophobe RCC=== | ||
Histomorphologic features useful to distinguish chromophobe RCC (eosinophilic variant) and oncocytoma:<ref name=pmid9844591>{{Cite journal | last1 = Tickoo | first1 = SK. | last2 = Amin | first2 = MB. | title = Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. | journal = Am J Clin Pathol | volume = 110 | issue = 6 | pages = 782-7 | month = Dec | year = 1998 | doi = | PMID = 9844591 }} | Histomorphologic features useful to distinguish chromophobe RCC (eosinophilic variant) and oncocytoma:<ref name=pmid9844591>{{Cite journal | last1 = Tickoo | first1 = SK. | last2 = Amin | first2 = MB. | title = Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. | journal = Am J Clin Pathol | volume = 110 | issue = 6 | pages = 782-7 | month = Dec | year = 1998 | doi = | PMID = 9844591 }}</ref> | ||
</ref> | {| class="wikitable sortable" | ||
{| class="wikitable" | ! Morphologic feature | ||
! [[ChRCC]] (eosinophilic<br> variant) | |||
! [[Renal oncocytoma]] | |||
|- | |- | ||
| Nuclear morphology | | Nuclear morphology | ||
| Line 130: | Line 144: | ||
|- | |- | ||
| Image | | Image | ||
| [ | | [[Image:Oncocytic_chromophobe_rcc_high_mag.jpg |thumb|150px|ChRCC (WC/Nephron)]] | ||
| [ | | [[Image:Renal_oncocytoma2.jpg |thumb|150px|Oncocytoma (WC/Nephron)]] | ||
|} | |} | ||
===Common DDx=== | |||
====Spindle cell tumours==== | |||
Malignant spindle cell tumours of the kidney: | |||
*[[Renal cell carcinoma with sarcomatoid differentiation]]. | |||
*[[Renal mucinous tubular and spindle cell carcinoma]]. | |||
*[[Wilms tumour]]. | |||
*[[Renal cell carcinoma, unclassified]]. | |||
Benign spindle cell tumours of the kidney: | |||
*[[Angiomyolipoma]]. | |||
*[[Cystic nephroma]]. | |||
====Renal tumours with eosinophilic cytoplasm==== | |||
{{Main|Renal tumours with eosinophilic cytoplasm}} | |||
=WHO classification of renal neoplasia= | |||
*Based on 2004 iteration - as per WMSP, slightly modified.<ref>{{Ref WMSP|291}}</ref> Online, the classification can [http://www.urosource.com/fileadmin/user_upload/european_urology/PIIS0302283805008316.pdf found here]. | |||
===Renal cell tumours=== | |||
Common: | |||
*[[Clear cell renal cell carcinoma]]. | |||
*[[Papillary renal cell carcinoma]]. | |||
*[[Renal papillary adenoma|Papillary adenoma]]. | |||
*[[Chromophobe renal cell carcinoma]]. | |||
*[[Renal oncocytoma|Oncocytoma]]. | |||
Less common: | |||
*[[Multilocular clear cell renal cell carcinoma]]. | |||
*[[Carcinoma of the collecting ducts of Bellini]]. | |||
*[[Renal cell carcinoma, unclassified]]. | |||
*[[Renal medullary carcinoma]]. | |||
*[[Renal tumour with Xp11.2 translocation|Xp11 translocation carcinoma]]. | |||
*[[Mucinous tubular and spindle cell carcinoma]]. | |||
*Carcinoma associated with neuroblastoma. | |||
===Metanephric tumours=== | |||
*[[Metanephric adenoma]]. | |||
*[[Metanephric stromal tumour]]. | |||
*[[Metanephric adenofibroma]]. | |||
===Nephroblastic tumours=== | |||
*Nephrogenic rests. | |||
*[[Nephroblastoma]]. | |||
===Mesenchymal tumours=== | |||
Childhood: | |||
*[[Clear cell sarcoma of the kidney]]. | |||
*[[Rhabdoid tumour]]. | |||
*[[Mesoblastic nephroma|Congenital mesoblastic nephroma]]. | |||
Adults: | |||
*Unique to kidney: | |||
**[[Juxtaglomerular cell tumour]]. | |||
**[[Renomedullary interstitial cell tumour]]. | |||
Other: | |||
*[[Angiomyolipoma]]. | |||
*[[Epithelioid angiomyolipoma]]. | |||
*[[Leiomyosarcoma]]. | |||
*[[Angiosarcoma]]. | |||
*[[Pleomorphic undifferentiated sarcoma]]. | |||
*[[Hemangiopericytoma]]. | |||
*[[Solitary fibrous tumour]]. | |||
*[[Osteosarcoma]]. | |||
*[[Schwannoma]]. | |||
===Mixed mesenchymal and epithelial tumours=== | |||
*[[Cystic nephroma]]. | |||
*[[Mixed epithelial and stromal tumour]]. | |||
*[[Synovial sarcoma]]. | |||
===Others=== | |||
*[[Neuroendocrine tumours]]. | |||
*Hematologic tumours. | |||
*[[Germ cell tumour]]s. | |||
*[[Metastases]]. | |||
==Vancouver modification of WHO classification== | |||
In 2012/2013, several additions were made:<ref name=pmid24025519>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | last3 = Eble | first3 = JN. | last4 = Egevad | first4 = L. | last5 = Epstein | first5 = JI. | last6 = Grignon | first6 = D. | last7 = Hes | first7 = O. | last8 = Moch | first8 = H. | last9 = Montironi | first9 = R. | title = The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. | journal = Am J Surg Pathol | volume = 37 | issue = 10 | pages = 1469-89 | month = Oct | year = 2013 | doi = 10.1097/PAS.0b013e318299f2d1 | PMID = 24025519 }}</ref> | |||
*[[Tubulocystic renal cell carcinoma]]. | |||
*[[Acquired cystic disease associated renal cell carcinoma]]. | |||
*[[Clear cell papillary renal cell carcinoma]] (clear cell tubulopapillary renal cell carcinoma). | |||
*[[Hereditary leiomyomatosis renal cell carcinoma syndrome associated renal cell carcinoma]]. | |||
*MiT family translocation renal cell carcinoma - includes: | |||
**[[t(6;11) renal cell carcinoma]]. | |||
"Emerging" entities (as per Vancouver) are: | |||
*[[Thyroid-like follicular renal cell carcinoma]]. | |||
*[[Succinate dehydrogenase-deficient renal cell carcinoma]]. | |||
*[[ALK translocation renal cell carcinoma]]. | |||
==Entities proposed after Vancouver== | |||
*[[Eosinophilic, solid and cystic renal cell carcinoma]] - part of 2022 WHO Classification. | |||
*[[Biphasic hyalinizing psammomatous renal cell carcinoma]]. | |||
*[[Papillary renal neoplasm with reverse polarity]]. | |||
*[[Low-grade oncocytic renal tumour]]. | |||
=Renal cell carcinoma= | =Renal cell carcinoma= | ||
| Line 139: | Line 248: | ||
*Relatively common form of cancer. | *Relatively common form of cancer. | ||
*Often abbreviated '''RCC'''. | *Often abbreviated '''RCC'''. | ||
*[[AKA]] ''hypernephroma''.<ref>URL:[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/]. Accessed on: 14 July 2011.</ref> | |||
*RCC represents approx. 90% of malignancies in kidneys of adults.<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> | |||
===Origin=== | ===Origin=== | ||
*Proximal renal tubule. | *Proximal renal tubule. | ||
| Line 151: | Line 261: | ||
===Risk factors=== | ===Risk factors=== | ||
*Smoking. | *[[Smoking]] - most important.<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> | ||
* | *Chemical exposures (arsenic, asbestos, cadmium, organic solvents, pesticides, fungal toxins).<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> | ||
* | *Chronic renal failure. | ||
**[[Acquired cystic renal disease]]. | |||
*Male>female (~2:1). | *Male>female (~2:1). | ||
*Hereditary - familial syndromes (see [[Hereditary RCC]]). | *Hereditary - familial syndromes (see [[Hereditary RCC]]). | ||
*[[Obesity]].<ref name=pmid8770461>{{Cite journal | last1 = Chow | first1 = WH. | last2 = McLaughlin | first2 = JK. | last3 = Mandel | first3 = JS. | last4 = Wacholder | first4 = S. | last5 = Niwa | first5 = S. | last6 = Fraumeni | first6 = JF. | title = Obesity and risk of renal cell cancer. | journal = Cancer Epidemiol Biomarkers Prev | volume = 5 | issue = 1 | pages = 17-21 | month = Jan | year = 1996 | doi = | PMID = 8770461 }}</ref> | |||
===Subtypes of RCC=== | ===Subtypes of RCC=== | ||
RCC (renal cell carcinoma) comes in different subtypes:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref> | RCC (renal cell carcinoma) comes in different subtypes:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref> | ||
*Clear cell carcinoma (70-80% of RCC) -- abbrev. CCRCC | *Clear cell carcinoma (70-80% of RCC) -- abbrev. CCRCC. | ||
*Papillary renal cell carcinoma (10-15% of RCC) -- abbrev. PRCC | *Papillary renal cell carcinoma (10-15% of RCC) -- abbrev. PRCC. | ||
*Chromophobe renal carcinoma (5% of RCC) -- abbrev. ChRCC | *Chromophobe renal carcinoma (5% of RCC) -- abbrev. ChRCC. | ||
*Collecting duct (Bellini duct) carcinoma (1% of RCC). | *Collecting duct (Bellini duct) carcinoma (1% of RCC). | ||
| Line 167: | Line 279: | ||
*Subtype is an independent predictor of mortality - but adds very little to multivariate models with staging information.<ref name=pmid19076149>{{Cite journal | last1 = Capitanio | first1 = U. | last2 = Cloutier | first2 = V. | last3 = Zini | first3 = L. | last4 = Isbarn | first4 = H. | last5 = Jeldres | first5 = C. | last6 = Shariat | first6 = SF. | last7 = Perrotte | first7 = P. | last8 = Antebi | first8 = E. | last9 = Patard | first9 = JJ. | title = A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. | journal = BJU Int | volume = 103 | issue = 11 | pages = 1496-500 | month = Jun | year = 2009 | doi = 10.1111/j.1464-410X.2008.08259.x | PMID = 19076149 }}</ref> | *Subtype is an independent predictor of mortality - but adds very little to multivariate models with staging information.<ref name=pmid19076149>{{Cite journal | last1 = Capitanio | first1 = U. | last2 = Cloutier | first2 = V. | last3 = Zini | first3 = L. | last4 = Isbarn | first4 = H. | last5 = Jeldres | first5 = C. | last6 = Shariat | first6 = SF. | last7 = Perrotte | first7 = P. | last8 = Antebi | first8 = E. | last9 = Patard | first9 = JJ. | title = A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. | journal = BJU Int | volume = 103 | issue = 11 | pages = 1496-500 | month = Jun | year = 2009 | doi = 10.1111/j.1464-410X.2008.08259.x | PMID = 19076149 }}</ref> | ||
*CCRCC tends to be worse than ChRCC and PRCC, probably due to higher incidence of mets.<ref name=pmid17886093>{{Cite journal | last1 = Delahunt | first1 = B. | last2 = Bethwaite | first2 = PB. | last3 = Nacey | first3 = JN. | title = Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. | journal = Pathology | volume = 39 | issue = 5 | pages = 459-65 | month = Oct | year = 2007 | doi = 10.1080/00313020701570061 | PMID = 17886093 }}</ref> | *CCRCC tends to be worse than ChRCC and PRCC, probably due to higher incidence of mets.<ref name=pmid17886093>{{Cite journal | last1 = Delahunt | first1 = B. | last2 = Bethwaite | first2 = PB. | last3 = Nacey | first3 = JN. | title = Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. | journal = Pathology | volume = 39 | issue = 5 | pages = 459-65 | month = Oct | year = 2007 | doi = 10.1080/00313020701570061 | PMID = 17886093 }}</ref> | ||
*The exam answer (worst to best): clear cell RCC, papillary RCC, chromophobe RCC. | |||
===IHC - is it RCC?=== | ===IHC - is it RCC?=== | ||
*RCC Ma (+), CD10 (+) -- specific for RCC<ref>{{cite journal |author=Zhou M, Roma A, Magi-Galluzzi C |title=The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |journal=Clin. Lab. Med. |volume=25 |issue=2 |pages=247?7 |year=2005 |month=June |pmid=15848735 |doi=10.1016/j.cll.2005.01.004 |url=}}</ref> | *RCC Ma (+), CD10 (+) -- specific for RCC<ref>{{cite journal |author=Zhou M, Roma A, Magi-Galluzzi C |title=The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |journal=Clin. Lab. Med. |volume=25 |issue=2 |pages=247?7 |year=2005 |month=June |pmid=15848735 |doi=10.1016/j.cll.2005.01.004 |url=}}</ref> | ||
| Line 175: | Line 289: | ||
*Papillary RCC type 1 vs. papillary RCC type 2: | *Papillary RCC type 1 vs. papillary RCC type 2: | ||
** E-cadherin +ve in PRCC type 2.<ref name=pmid14657952>{{cite journal |author=Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R |title=Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases |journal=Mod. Pathol. |volume=17 |issue=2 |pages=180? |year=2004 |month=February |pmid=14657952 |doi=10.1038/modpathol.3800032 |url=}}</ref> | ** E-cadherin +ve in PRCC type 2.<ref name=pmid14657952>{{cite journal |author=Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R |title=Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases |journal=Mod. Pathol. |volume=17 |issue=2 |pages=180? |year=2004 |month=February |pmid=14657952 |doi=10.1038/modpathol.3800032 |url=}}</ref> | ||
**EMA (MUC1) +ve in PRCC type 1.<ref name=pmid14657952/> | **[[EMA]] (MUC1) +ve in PRCC type 1.<ref name=pmid14657952/> | ||
*ChRCC vs. oncocytoma (ONC): | *ChRCC vs. oncocytoma (ONC): | ||
| Line 197: | Line 311: | ||
*E-cadherin ''not'' useful for differentiating ChRCC and ONC.<ref name=pmid12613443>{{cite journal |author=Kim MK, Kim S |title=Immunohistochemical profile of common epithelial neoplasms arising in the kidney |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=4 |pages=332–8 |year=2002 |month=December |pmid=12613443 |doi= |url=}}</ref> | *E-cadherin ''not'' useful for differentiating ChRCC and ONC.<ref name=pmid12613443>{{cite journal |author=Kim MK, Kim S |title=Immunohistochemical profile of common epithelial neoplasms arising in the kidney |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=4 |pages=332–8 |year=2002 |month=December |pmid=12613443 |doi= |url=}}</ref> | ||
== | ===RCC vs. Urothelial cell carcinoma=== | ||
{{main|Urothelium}} | {{main|Urothelium}} | ||
*Clinically/radiologically, it may not be possible to differentiate renal pelvis UCC and RCC if the tumour is large. | *Clinically/radiologically, it may not be possible to differentiate renal pelvis UCC and RCC if the tumour is large. | ||
*Pathologically, this is not very difficult. | *Pathologically, this is not very difficult. | ||
*On gross specimens, it is almost always obvious what one is dealing with: | *On gross specimens, it is almost always obvious what one is dealing with: | ||
**UCC = ''nephroureterectomy''. | **[[UCC]] = ''[[nephroureterectomy]]''. | ||
**RCC = ''partial nephrectomy'', ''nephrectomy'' or ''radical nephrectomy''. | **[[RCC]] = ''[[partial nephrectomy]]'', ''nephrectomy'' or ''[[radical nephrectomy]]''. | ||
= | ===Renal cell carcinoma with sarcomatoid differentiation=== | ||
*[[AKA]] ''sarcomatoid renal cell carcinoma''. | |||
{{Main|Renal cell carcinoma with sarcomatoid differentiation}} | |||
== | ===Renal cell carcinoma with rhabdoid morphology=== | ||
*[[AKA]] ''renal cell carcinoma with rhabdoid change''. | |||
* | {{Main|Renal cell carcinoma with rhabdoid morphology}} | ||
=== | ==Hereditary renal cell carcinoma== | ||
{{Main|Hereditary renal cell carcinoma}} | |||
==Renal cell carcinoma grading== | |||
{{Main|Renal cell carcinoma grading}} | |||
=== | ==Renal cell carcinoma staging== | ||
{{Main|Kidney cancer staging}} | |||
===Renal sinus invasion=== | |||
{{Main|Kidney cancer staging}} | |||
==Clear cell renal cell carcinoma== | |||
{{Main|Clear cell renal cell carcinoma}} | |||
== | ==Multilocular cystic renal cell carcinoma== | ||
{{Main|Multilocular cystic renal cell carcinoma}} | |||
=== | ==Papillary renal cell carcinoma== | ||
{{Main|Papillary renal cell carcinoma}} | |||
== | ==Chromophobe renal cell carcinoma== | ||
{{Main|Chromophobe renal cell carcinoma}} | |||
==== | ==Clear cell papillary renal cell tumour== | ||
In the past, it was known as ''clear cell papillary renal cell carcinoma''. | |||
{{Main|Clear cell papillary renal cell tumour}} | |||
== | ==Unclassified renal cell carcinoma== | ||
* | *Abbreviated ''URCC''. | ||
{{Main|Unclassified renal cell carcinoma}} | |||
=Renal translocation carcinomas= | |||
==Renal tumour with Xp11.2 translocation== | |||
{{Main|Renal tumour with Xp11.2 translocation}} | |||
== | ==Renal tumour with t(6;11) translocation== | ||
*[[AKA]] ''t(6;11) renal cell carcinoma''. | |||
* | {{main|Renal tumour with t(6;11) translocation}} | ||
=== | =Benign tumours= | ||
* | ==Papillary adenoma of the kidney== | ||
*[[AKA]] ''renal papillary adenoma''. | |||
{{Main|Papillary adenoma of the kidney}} | |||
==Renal oncocytoma== | |||
{{Main|Renal oncocytoma}} | |||
== | ==Angiomyolipoma== | ||
* | *Abbreviated ''AML''. | ||
{{Main|Angiomyolipoma}} | |||
=Mimics= | |||
==Xanthogranulomatous pyelonephritis== | |||
* | *Abbreviated ''XGP''. | ||
{{Main|Xanthogranulomatous pyelonephritis}} | |||
==Malakoplakia== | ==Malakoplakia== | ||
| Line 440: | Line 388: | ||
=Rare stuffs= | =Rare stuffs= | ||
== | ==Juxtaglomerular cell tumour== | ||
=== | *[[AKA]] juxtaglomerular tumour, reninoma.<ref name=pmid18192852>{{Cite journal | last1 = Wong | first1 = L. | last2 = Hsu | first2 = TH. | last3 = Perlroth | first3 = MG. | last4 = Hofmann | first4 = LV. | last5 = Haynes | first5 = CM. | last6 = Katznelson | first6 = L. | title = Reninoma: case report and literature review. | journal = J Hypertens | volume = 26 | issue = 2 | pages = 368-73 | month = Feb | year = 2008 | doi = 10.1097/HJH.0b013e3282f283f3 | PMID = 18192852 }}</ref> | ||
{{Main|Juxtaglomerular cell tumour}} | |||
=== | ==Renomedullary interstitial cell tumour== | ||
*[[AKA]] ''medullary fibroma''.<ref name=pmid11054036 >{{Cite journal | last1 = Bircan | first1 = S. | last2 = Orhan | first2 = D. | last3 = Tulunay | first3 = O. | last4 = Safak | first4 = M. | title = Renomedullary interstitial cell tumor. | journal = Urol Int | volume = 65 | issue = 3 | pages = 163-6 | month = | year = 2000 | doi = | PMID = 11054036 }}</ref> | |||
{{Main|Renomedullary interstitial cell tumour}} | |||
=== | |||
=== | |||
==Metanephric adenoma== | ==Metanephric adenoma== | ||
*Should '''not''' be confused ''[[mesonephric adenoma]]'', another term for ''nephrogenic adenoma''. | |||
* | **Memory device: me'''t'''anephric adenoma is a '''t'''umour. | ||
{{Main|Metanephric adenoma}} | |||
** | |||
==Renal epithelial and stromal tumour== | |||
:Abbreviated ''REST''. | |||
The lumping term for both:<ref name=pmid17414095>{{Cite journal | last1 = Turbiner | first1 = J. | last2 = Amin | first2 = MB. | last3 = Humphrey | first3 = PA. | last4 = Srigley | first4 = JR. | last5 = De Leval | first5 = L. | last6 = Radhakrishnan | first6 = A. | last7 = Oliva | first7 = E. | title = Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. | journal = Am J Surg Pathol | volume = 31 | issue = 4 | pages = 489-500 | month = Apr | year = 2007 | doi = 10.1097/PAS.0b013e31802bdd56 | PMID = 17414095 }}</ref> | |||
#[[Mixed epithelial and stromal tumour]]. | |||
#[[Cystic nephroma]]. | |||
==Mixed epithelial and stromal tumour== | |||
* | *Abbreviated ''MEST''. | ||
{{Main|Mixed epithelial and stromal tumour of the kidney}} | |||
==Cystic nephroma== | ==Cystic nephroma== | ||
{{Main|Cystic nephroma}} | |||
==Renal mucinous tubular and spindle cell carcinoma== | ==Renal mucinous tubular and spindle cell carcinoma== | ||
*[[AKA]] ''renal mucinous tubular spindle cell carcinoma''. | |||
* | *[[AKA]] ''mucinous tubular and spindle cell carcinoma of the kidney''.<ref name=pmid16258504>{{Cite journal | last1 = Brandal | first1 = P. | last2 = Lie | first2 = AK. | last3 = Bassarova | first3 = A. | last4 = Svindland | first4 = A. | last5 = Risberg | first5 = B. | last6 = Danielsen | first6 = H. | last7 = Heim | first7 = S. | title = Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. | journal = Mod Pathol | volume = 19 | issue = 2 | pages = 186-94 | month = Feb | year = 2006 | doi = 10.1038/modpathol.3800499 | PMID = 16258504 }}</ref> | ||
{{Main|Renal mucinous tubular and spindle cell carcinoma}} | |||
== | ==Collecting duct carcinoma== | ||
{{Main|Collecting duct carcinoma}} | |||
==Renal medullary carcinoma== | |||
{{Main|Renal medullary carcinoma}} | |||
== | ==Tubulocystic carcinoma of the kidney== | ||
{{Main|Tubulocystic carcinoma of the kidney}} | |||
== | ==Acquired cystic disease-associated renal cell carcinoma== | ||
{{Main|Acquired cystic disease-associated renal cell carcinoma}} | |||
=== | ==Kidney metastasis== | ||
*[[AKA]] ''renal metastasis'', ''metastatic kidney disease''. | |||
{{Main|Kidney metastasis}} | |||
*[[ | |||
=Pediatric= | =Pediatric= | ||
{{Main|Pediatric kidney tumours}} | |||
The most common is [[nephroblastoma]] (Wilms tumour). | |||
Others include: | |||
* | *[[Metanephric stromal tumour]]. | ||
* | *[[Metanephric adenofibroma]] | ||
*[[Metanephric adenoma]]. | |||
*[[Clear cell sarcoma of the kidney]]. | |||
=See also= | =See also= | ||
| Line 592: | Line 453: | ||
=References= | =References= | ||
{{reflist|2}} | {{reflist|2}} | ||
=External links= | |||
*[http://www.uscap.org/site~/99th/pdf/companion13h03.pdf Renal tumours with eosinophilic cytoplasm (uscap.org)]. | |||
[[Category: Genitourinary pathology]] | [[Category: Genitourinary pathology]] | ||